A regimen consisting of gemcitabine and oxaliplatin used for the treatment of biliary adenocarcinoma, pancreatic cancer, hepatocellular cancer, and testicular cancer. This regimen is currently being studied in a variety of other cancers. Or A chemotherapy combination used to treat pancreatic cancer and some other types of cancer. It includes the drugs gemcitabine hydrochloride and oxaliplatin. Also called gemcitabine-oxaliplatin and GEMOX.